Protein O-fucosyltransferase 1: A potential diagnostic marker and therapeutic target for human oral cancer

Yokota,Satoshi; Ogawara,Katsunori; Kimura,Ryota; Shimizu,Fumie; Baba,Takao; Minakawa,Yasuyuki; Higo,Morihiro; Kasamatsu,Atsushi; Endo-Sakamoto,Yosuke; Shiiba,Masashi; Tanzawa,Hideki; Uzawa,Katsuhiro

doi:10.3892/ijo.2013.2110

Protein O-fucosyltransferase 1: A potential diagnostic marker and therapeutic target for human oral cancer

Authors:
- Satoshi Yokota
- Katsunori Ogawara
- Ryota Kimura
- Fumie Shimizu
- Takao Baba
- Yasuyuki Minakawa
- Morihiro Higo
- Atsushi Kasamatsu
- Yosuke Endo-Sakamoto
- Masashi Shiiba
- Hideki Tanzawa
- Katsuhiro Uzawa
View Affiliations

Affiliations: Department of Clinical Molecular Biology, Graduate School of Medicine, Chiba University, Chuo-ku, Chiba 260-8670, Japan, Division of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital, Chuo-ku, Chiba 260-8677, Japan, Department of Clinical Oncology, Graduate School of Medicine, Chiba University, Chuo-ku, Chiba 260-8670, Japan
Published online on: September 23, 2013 https://doi.org/10.3892/ijo.2013.2110
Pages: 1864-1870

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Protein O-fucosyltransferase 1 (POFUT1) is the enzyme that adds O-fucose through O-glycosidic linkage to conserved serine or threonine residues in the epidermal growth factor-like repeats of a number of cellular surface and secreted proteins. Our previous study using microarray technology showed that significant upregulation of POFUT1 occurs in oral squamous cell carcinoma (OSCC)-derived cell lines compared to human normal oral keratinocytes. The aim of the present study was to examine the status of POFUT1 mRNA and protein expression in OSCC-derived cell lines and human primary OSCCs. POFUT1 mRNA was upregulated significantly (P<0.05 for both comparisons) in five OSCC-derived cell lines and primary OSCCs using quantitative reverse transcriptase-polymerase chain reaction. Immunohistochemistry data indicated that POFUT1 protein expression levels were consistent with mRNA expression status in OSCC-derived cell lines and primary OSCCs. Furthermore, POFUT1 expression status was correlated significantly (P=0.048) with the primary tumor size. The proliferation of POFUT1 knockdown cells was inhibited significantly compared with that of control cells. These results indicated that POFUT1 expression can contribute to cancer progression and that POFUT1 may serve as a diagnostic marker and a therapeutic target for OSCCs.

View Figures

View References

1.	Severino P, Alvares AM, Michaluart P Jr, Okamoto OK, Nunes FD, Moreira-Filho CA and Tajara EH: Global gene expression profiling of oral cavity cancers suggests molecular heterogeneity within anatomic subsites. BMC Res Notes. 1:113–121. 2008. View Article : Google Scholar : PubMed/NCBI
2.	Scully C, Field JK and Tanzawa H: Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol. 36:256–263. 2000. View Article : Google Scholar : PubMed/NCBI
3.	Scully C, Field JK and Tanzawa H: Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinicopathological applications. Oral Oncol. 36:404–413. 2000. View Article : Google Scholar : PubMed/NCBI
4.	Sticht C, Freier K, Knöpfle K, Flechtenmacher C, Pungs S, Hofele C, Hahn M, Joos S and Lichter P: Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC). Neoplasia. 10:462–470. 2008.PubMed/NCBI
5.	Macfarlane GJ, Zheng T, Marshall JR, Boffetta P, Niu S, Brasure J, Merletti F and Boyle P: Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. Eur J Cancer B Oral Oncol. 31B:181–187. 1995. View Article : Google Scholar : PubMed/NCBI
6.	Yamano Y, Uzawa K, Shinozuka K, Fushimi K, Ishigami T, Nomura H, Ogawara K, Shiiba M, Yokoe H and Tanzawa H: Hyaluronan-mediated motility: a target in oral squamous cell carcinoma. Int J Oncol. 32:1001–1009. 2008.PubMed/NCBI
7.	Wang Y, Lee GF, Kelley RF and Spellman MW: Identification of a GDP-L-fucose: polypeptide fucosyltransferase and enzymatic addition of O-linked fucose to EGF domains. Glycobiology. 6:837–842. 1996. View Article : Google Scholar : PubMed/NCBI
8.	Koike H, Uzawa K, Grzesik WJ, Seki N, Endo Y, Kasamatsu A, Yamauchi M and Tanzawa H: GLUT1 is highly expressed in cementoblasts but not in osteoblasts. Connect Tissue Res. 46:117–124. 2005. View Article : Google Scholar : PubMed/NCBI
9.	Kasamatsu A, Uzawa K, Nakashima D, Koike H, Shiiba M, Bukawa H, Yokoe H and Tanzawa H: Galectin-9 as a regulator of cellular adhesion in human oral squamous cell carcinoma cell lines. Int J Mol Med. 16:269–273. 2005.PubMed/NCBI
10.	Endo Y, Uzawa K, Mochida Y, Shiiba M, Bukawa H, Yokoe H and Tanzawa H: Sarcoendoplasmic reticulum Ca(2+) ATPase type 2 downregulated in human oral squamous cell carcinoma. Int J Cancer. 110:225–231. 2004.
11.	Sakuma K, Kasamatsu A, Yamatoji M, Yamano Y, Fushimi K, Iyoda M, Ogoshi K, Shinozuka K, Ogawara K, Shiiba M, Tanzawa H and Uzawa K: Expression status of Zic family member 2 as a prognostic marker for oral squamous cell carcinoma. J Cancer Res Clin Oncol. 136:553–559. 2010. View Article : Google Scholar : PubMed/NCBI
12.	Yamatoji M, Kasamatsu A, Kouzu Y, Koike H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and Uzawa K: Dermatopontin: a potential predictor for metastasis of human oral cancer. Int J Cancer. 130:2903–2911. 2012. View Article : Google Scholar : PubMed/NCBI
13.	Yamatoji M, Kasamatsu A, Yamano Y, Sakuma K, Ogoshi K, Iyoda M, Shinozuka K, Ogawara K, Takiguchi Y, Shiiba M, Tanzawa H and Uzawa K: State of homeobox A10 expression as a putative prognostic marker for oral squamous cell carcinoma. Oncol Rep. 23:61–67. 2010.PubMed/NCBI
14.	Kato Y, Uzawa K, Yamamoto N, Kouzu Y, Koike H, Shiiba M, Bukawa H, Yokoe H, Shibahara T and Tanzawa H: Overexpression of Septin1: possible contribution to the development of oral cancer. Int J Oncol. 31:1021–1028. 2007.PubMed/NCBI
15.	Kouzu Y, Uzawa K, Koike H, Saito K, Nakashima D, Higo M, Endo Y, Kasamatsu A, Shiiba M, Bukawa H, Yokoe H and Tanzawa H: Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis. Br J Cancer. 94:717–723. 2006.PubMed/NCBI
16.	Iyoda M, Kasamatsu A, Ishigami T, Nakashima D, Endo-Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and Uzawa K: Epithelial cell transforming sequence 2 in human oral cancer. PLoS One. 5:e140822010. View Article : Google Scholar : PubMed/NCBI
17.	Onda T, Uzawa K, Nakashima D, Saito K, Iwadate Y, Seki N, Shibahara T and Tanzawa H: Lin-7C/VELI3/MALS-3: an essential component in metastasis of human squamous cell carcinoma. Cancer Res. 67:9643–9648. 2007. View Article : Google Scholar : PubMed/NCBI
18.	Saito Y, Kasamatsu A, Yamamoto A, Shimizu T, Yokoe H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and Uzawa K: ALY as a potential contributor to metastasis in human oral squamous cell carcinoma. J Cancer Res Clin Oncol. 139:585–594. 2013. View Article : Google Scholar : PubMed/NCBI
19.	Koike K, Kasamatsu A, Iyoda M, Saito Y, Kouzu Y, Koike H, Sakamoto Y, Ogawara K, Tanzawa H and Uzawa K: High prevalence of epigenetic inactivation of the human four and a half LIM domains 1 gene in human oral cancer. Int J Oncol. 42:141–150. 2013.PubMed/NCBI
20.	Usukura K, Kasamatsu A, Okamoto A, Kouzu Y, Higo M, Koike H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and Uzawa K: Tripeptidyl peptidase II in human oral squamous cell carcinoma. J Cancer Res Clin Oncol. 139:123–130. 2013. View Article : Google Scholar : PubMed/NCBI
21.	Verburg FA, Wäschle K, Reiners C, Giovanella L and Lentjes EG: Heterophile antibodies rarely influence the measurement of thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer patients. Horm Metab Res. 42:736–739. 2010. View Article : Google Scholar
22.	Imam JS, Buddavarapu K, Lee-Chang JS, Ganapathy S, Camosy C, Chen Y and Rao MK: MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers. Oncogene. 29:4971–4979. 2010. View Article : Google Scholar : PubMed/NCBI
23.	Ogoshi K, Kasamatsu A, Iyoda M, Sakuma K, Yamatoji M, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and Uzawa K: Dickkopf-1 in human oral cancer. Int J Oncol. 39:329–336. 2011.PubMed/NCBI
24.	Schuster-Gossler K, Harris B, Johnson KR, Serth J and Gossler A: Notch signalling in the paraxial mesoderm is most sensitive to reduced POFUT1 levels during early mouse development. BMC Dev Biol. 9:62009. View Article : Google Scholar : PubMed/NCBI
25.	Stanley P and Guidos CJ: Regulation of Notch signaling during T- and B-cell development by O-fucose glycans. Immunol Rev. 230:201–215. 2009. View Article : Google Scholar : PubMed/NCBI
26.	Gurvich N, Perna F, Farina A, Voza F, Menendez S, Hurwitz J and Nimer SD: L3MBTL1 polycomb protein, a candidate tumor suppressor in del(20q12) myeloid disorders, is essential for genome stability. Proc Natl Acad Sci USA. 107:22552–22557. 2010. View Article : Google Scholar : PubMed/NCBI
27.	Mackinnon RN, Selan C, Wall M, Baker E, Nandurkar H and Campbell LJ: The paradox of 20q11.21 amplification in a subset of cases of myeloid malignancy with chromosome 20 deletion. Genes Chromosomes Cancer. 49:998–1013. 2010. View Article : Google Scholar : PubMed/NCBI
28.	Kroes RA, Dawson G and Moskal JR: Focused microarray analysis of glycogene expression in human glioblastomas. J Neurochem. 103(Suppl 1): 14–24. 2007. View Article : Google Scholar
29.	Loo LW, Tiirikainen M, Cheng I, Lum-Jones A, Seifried A, Church JM, Gryfe R, Weisenberger DJ, Lindor NM, Gallinger S, Haile RW, Duggan DJ, Thibodeau SN, Casey G and Le Marchand L: Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer. Genes Chromosomes Cancer. 52:450–466. 2013. View Article : Google Scholar : PubMed/NCBI